Skip to main content

Market Overview

MLV & Co. Initiates Evoke Pharma At Hold

Share:

Analysts at MLV & Co. initiated coverage on Evoke Pharma (NASDAQ: EVOK) with a Buy rating.

The target price for Evoke Pharma is set to $12.50.

Evoke Pharma shares have dropped 31.96% over the past 52 weeks, while the S&P 500 index has gained 14.72% in the same period.

Evoke Pharma's shares rose 0.15% to close at $6.62 yesterday.

Latest Ratings for EVOK

DateFirmActionFromTo
Jun 2020HC Wainwright & Co.UpgradesNeutralBuy
Mar 2019HC Wainwright & Co.DowngradesBuyNeutral
Oct 2017FBR CapitalReinstatesBuy

View More Analyst Ratings for EVOK

View the Latest Analyst Ratings

 

Related Articles (EVOK)

View Comments and Join the Discussion!

Posted-In: MLV & Co.Initiation Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com